Lego is Most Reputable Company in 2018 Across EU5 Countries Germany, France, Spain, Italy and UK
September 20, 2018 02:00 ET
|
Reputation Institute
Boston, MA, Sept. 20, 2018 (GLOBE NEWSWIRE) -- Reputation Institute (RI), the global leader in reputation intelligence, today announced the 2018 EU5 RepTrak® rankings. The largest corporate...
Corbus Pharmaceuticals Receives Orphan Designation for Lenabasum for the Treatment of Dermatomyositis in the European Union
September 18, 2018 08:05 ET
|
Corbus Pharmaceuticals Holdings, Inc.
– Dermatomyositis is a rare chronic systemic autoimmune disease characterized by inflammation of muscles and skin – DM affects ~80,000 in the US, EU and Japan and has a 5-year mortality rate as...
Veritas Appoints Mr. Filios Theodorou as Its Agent for Cyprus and SEMEA Countries
June 25, 2018 03:15 ET
|
Veritas Pharma Inc.
VANCOUVER, British Columbia, June 25, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt: 2VP) (“Veritas” or the “Company”) is pleased to announce that Mr. Filios...
Maricann: A Unique & Undervalued Licensed Producer with a Global Focus -- CFN Media
May 29, 2018 08:40 ET
|
CFN Media
Seattle, WA. , May 29, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, today announced...
Only 14 Percent of Organizations Fully Prepared for GDPR Requirements Despite Enforcement Later This Month
May 10, 2018 08:00 ET
|
HyTrust
MOUNTAIN VIEW, Calif., May 10, 2018 (GLOBE NEWSWIRE) -- HyTrust announced today results from a survey of security professionals revealing that only 14 percent of organizations believe that they are...
Psychological Effects of Ovarian Cancer Often Overlooked and Can Have a Significant Impact on Patients
May 08, 2018 09:19 ET
|
TESARO, Inc.
79% of patients felt uncomfortable raising psychological and emotional concerns during their consultations1Disease recurrence is of greatest concern for ovarian cancer patients, but poorly addressed,...
DISC Publisher, PeopleKeys, Announces GDPR Readiness
May 02, 2018 02:00 ET
|
PeopleKeys
Youngstown, Ohio USA, May 02, 2018 (GLOBE NEWSWIRE) -- PeopleKeys, the leader in behavioral instruments and understanding, is proud to announce its preparation for the new landmark data privacy...
Global Insurance Symposium Announces Final Keynote on General Data Protection Regulation and the European Union
April 23, 2018 17:45 ET
|
Global Insurance Symposium
DES MOINES, Iowa, April 23, 2018 (GLOBE NEWSWIRE) -- The 2018 Global Insurance Symposium (GIS) today announced Aegon Global Chief Technology Officer and Member of the Management Board, Mark Bloom,...
TESARO Announces Availability of ZEJULA® (niraparib) for Women With Recurrent Ovarian Cancer in Germany
December 15, 2017 04:00 ET
|
TESARO, Inc.
ZEJULA is the first PARP inhibitor approved in Europe for women with recurrent ovarian cancer, without the need for BRCA testing and regardless of biomarker statusZEJULA is the only PARP inhibitor to...
TESARO Announces European Commission Approval of ZEJULA® for Women With Recurrent Ovarian Cancer
November 20, 2017 07:00 ET
|
TESARO, Inc.
ZEJULA is the first PARP inhibitor approved in Europe for women with recurrent ovarian cancer, regardless of BRCA mutation or biomarker statusApproval supported by robust data from a randomized,...